Cour Pharmaceuticals Development Co., Inc.’s Post

If you’re attending the Myasthenia Gravis Foundation of America, Inc.’s 2024 National Patient Conference in Tampa, don’t miss our booth! We look forward to discussing our #MyastheniaGravis research, including the #ClinicalTrial of our potential treatment, CNP-106. Learn more about our study here: https://lnkd.in/eiQcxG8M 

  • No alternative text description for this image

We look forward to welcoming you this weekend!

Like
Reply

To view or add a comment, sign in

Explore topics